This clinical trial focuses on patients undergoing cardiac surgery who are at intermediate or high risk of complications. The study aims to test if extended treatment with corticosteroid medications can help prevent complications after heart surgery. The main medications being studied are hydrocortisone (given through an infusion into a vein) and fludrocortisone (given as tablets) compared to inactive substances (placebo).
The treatment will last for 5 days and will be given to patients who need heart surgery that uses a heart-lung bypass machine (a device that temporarily takes over the function of the heart and lungs during surgery). The study will look at whether these medications can help prevent several complications that can occur after surgery, including acute renal failure (sudden loss of kidney function), breathing problems, and the need for medications to maintain blood pressure.
Patients will receive either the combination of both medications or inactive substances that look the same as the real medications. The study will monitor patients for various side effects and complications for up to 28 days after their surgery. Some of the things being watched for include problems with salt levels in the blood, high blood sugar, infections, and any effects on the heart or brain.



France